FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

FORTIS Share Price Target

Fortis Healthcare Ltd.
Sector: Pharmaceuticals and health care
... Read more
FORTIS Long Term Analysts Rating
0/5 (0 Ratings)
FORTIS Share Price *
153.35 +7.2 (4.93%)
* (quote may be delayed)

0 FORTIS share price target reports by brokerages below. See what is analyst's view on FORTIS share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.


You can also find FORTIS share price target tomorrow or next week from FORTIS discussion forum.

FORTIS Share Price Forecast - Consensus
No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
NaN
Consensus Potential
NaN%

FORTIS Share Price Target - Broker Reports - 2018

ICICIdirect.com
16-Mar-18
Price @ Call: 157.43
Target: 200
BUY

Motilal Oswal
1-Mar-18
Price @ Call: 161.27
Target: 185
BUY

FORTIS Share Price Target - Broker Reports - 2017

Motilal Oswal
16-Nov-17
Price @ Call: 140.45
Target: 185
BUY

Axis Direct
10-Aug-17
Price @ Call: 158.65
Target: 191
BUY

Motilal Oswal
8-Aug-17
Price @ Call: 162.1
Target: 220
BUY

Edelweiss
4-Aug-17
Price @ Call: 166
Target: 230
BUY

Motilal Oswal
4-Aug-17
Price @ Call: 166
Target: 220
BUY

ICICIdirect.com
10-Jul-17
Price @ Call: 158.35
Target: 198
BUY

Motilal Oswal
20-Jun-17
Price @ Call: 198
Target: 240
BUY

Motilal Oswal
21-Apr-17
Price @ Call: 204
Target: 250
BUY

FORTIS Share Price Target - Broker Reports - 2016

Axis Direct
11-Nov-16
Price @ Call: 165
Target: 204
BUY

Motilal Oswal
17-Oct-16
Price @ Call: 184.8
Target: 240
BUY

Axis Direct
23-Aug-16
Price @ Call: 188
Target: 209
HOLD

SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.